Methods

HTA di dispositivi medici: alleanza di competenze tra Direzione Sanitaria e Farmacia in un percorso condiviso

DOI 10.23753/htafocus2014.02.011

Claudia Fruttero, Francesco Cattel, Franco Ripa, Arianna Vitale

Abstract

Introduction: During 2013 collaboration between SIFO (Italian Society of Hospital Pharmacist) and ANMDO (National Association of Medical Hospital Direction) promoted a scientific collaboration in Piedmont, developed in a 3 days training course. This course talked about the development of shared procedures that evaluated, according to HTA, medicines, major biomedical technological equipments and medical devices (MD).
The participants (Hospital Pharmacists and Health Managers) were divided in three groups and each group received the task to write an evidence-based procedure: first on medicines, second on major biomedical technological equipments and the last one, called medical devices group, on MD.
The shared procedure for the MD was the subject of the homework.
Methods: By a questionnaire the MD tutors collected roles and activities of colleagues. The group was divided into two subgroups, each of one composed of the same number of Health Managers and Pharmacists. One subgroup started a research for legislation (Legislation Subgroup) and the other for literature of MDs’ assessment (Subgroup scientific evidences). For both subgroups was identified a referral, respectively a pharmacist and a Health Manager.
The tutors made a benchmarking collection of DM acquisition procedures, in use in the colleagues’ hospitals. The aim was to underline similarities and transfer elements.
Results: The final document summarized the results of researches, focused on scope, terminology, and abbreviations. This will be transferred in all Piedmont hospitals and also proposed in extra-regional hospitals and health care agencies. This experience has been possible thanks to a common path between DMPO’s Physicians and hospital Pharmacists. In all contests collaboration led to innovation and change, leading to sustainability of the new public health!

Key words: evidence/legislation-based technology assessment, medical devices

Cluster Edizioni è un marchio di Cluster s.r.l.

P.IVA 07530720015

© 2019 Cluster Edizioni - tutti i diritti riservati 

  • Facebook Clean Grey
  • LinkedIn Clean Grey